What Charlie said. What Mike did.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +1.5% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 20 share(s), worth $13,802.00, or 7.2% of the portfolio.
• Estimated current price from Schwab market value is $690.10.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for VOO.
• VOO is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -0.8% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 30 share(s), worth $11,577.00, or 6.0% of the portfolio.
• Estimated current price from Schwab market value is $385.90.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for GOOGL.
• GOOGL is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +306.6% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 149 share(s), worth $11,507.27, or 6.0% of the portfolio.
• Estimated current price from Schwab market value is $77.23.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMB.
• WMB is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -1.0% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 50 share(s), worth $10,866.00, or 5.7% of the portfolio.
• Estimated current price from Schwab market value is $217.32.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for NVDA.
• NVDA is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +1.3% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 40 share(s), worth $10,744.40, or 5.6% of the portfolio.
• Estimated current price from Schwab market value is $268.61.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for AMZN.
• AMZN is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +15.7% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 59 share(s), worth $7,100.06, or 3.7% of the portfolio.
• Estimated current price from Schwab market value is $120.34.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMT.
• WMT is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab, IBD article API, MarketSurge, and market quotes are fresh enough for required checks.
• 2 deeper required source surface(s) still need coverage before Charlie should make buy calls.
• IBD market exposure / home
• IBD Big Picture

Schwab changed

• Schwab account context is available, so Charlie can guard against duplicate or oversized buys.
• Before adding risk, review current positions and missing stop prices.

Charlie reasoned

• This is a no-new-buy state, not a no-advice state: Charlie can still recommend stop-loss cleanup from Schwab data.
• Charlie can still help Mike review existing positions, stops, source headlines, and watch candidates while he gathers the missing evidence.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +0.9% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 20 share(s), worth $13,711.00, or 7.2% of the portfolio.
• Estimated current price from Schwab market value is $685.55.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for VOO.
• VOO is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +313.1% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 149 share(s), worth $11,692.03, or 6.1% of the portfolio.
• Estimated current price from Schwab market value is $78.47.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMB.
• WMB is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -1.5% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 30 share(s), worth $11,489.10, or 6.0% of the portfolio.
• Estimated current price from Schwab market value is $382.97.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for GOOGL.
• GOOGL is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -1.9% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 50 share(s), worth $10,766.50, or 5.6% of the portfolio.
• Estimated current price from Schwab market value is $215.33.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for NVDA.
• NVDA is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +0.5% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 40 share(s), worth $10,652.80, or 5.6% of the portfolio.
• Estimated current price from Schwab market value is $266.32.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for AMZN.
• AMZN is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +15.7% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 59 share(s), worth $7,095.93, or 3.7% of the portfolio.
• Estimated current price from Schwab market value is $120.27.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMT.
• WMT is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab, IBD article API, MarketSurge, and market quotes are fresh enough for required checks.
• 2 deeper required source surface(s) still need coverage before Charlie should make buy calls.
• IBD market exposure / home
• IBD Big Picture

Schwab changed

• Schwab account context is available, so Charlie can guard against duplicate or oversized buys.
• Before adding risk, review current positions and missing stop prices.

Charlie reasoned

• This is a no-new-buy state, not a no-advice state: Charlie can still recommend stop-loss cleanup from Schwab data.
• Charlie can still help Mike review existing positions, stops, source headlines, and watch candidates while he gathers the missing evidence.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +0.9% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 20 share(s), worth $13,711.00, or 7.2% of the portfolio.
• Estimated current price from Schwab market value is $685.55.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for VOO.
• VOO is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +313.1% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 149 share(s), worth $11,692.03, or 6.1% of the portfolio.
• Estimated current price from Schwab market value is $78.47.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMB.
• WMB is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -1.5% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 30 share(s), worth $11,489.10, or 6.0% of the portfolio.
• Estimated current price from Schwab market value is $382.97.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for GOOGL.
• GOOGL is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -1.9% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 50 share(s), worth $10,766.50, or 5.6% of the portfolio.
• Estimated current price from Schwab market value is $215.33.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for NVDA.
• NVDA is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +0.5% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 40 share(s), worth $10,652.80, or 5.6% of the portfolio.
• Estimated current price from Schwab market value is $266.32.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for AMZN.
• AMZN is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +15.7% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 59 share(s), worth $7,095.93, or 3.7% of the portfolio.
• Estimated current price from Schwab market value is $120.27.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMT.
• WMT is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab, IBD article API, MarketSurge, and market quotes are fresh enough for required checks.
• 2 deeper required source surface(s) still need coverage before Charlie should make buy calls.
• IBD market exposure / home
• IBD Big Picture

Schwab changed

• Schwab account context is available, so Charlie can guard against duplicate or oversized buys.
• Before adding risk, review current positions and missing stop prices.

Charlie reasoned

• This is a no-new-buy state, not a no-advice state: Charlie can still recommend stop-loss cleanup from Schwab data.
• Charlie can still help Mike review existing positions, stops, source headlines, and watch candidates while he gathers the missing evidence.

Source evidence

• IBD list evidence: IBD Leaderboard, MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 84, Group Rank 145.
• IBD article context: IBD Leaderboard member evidence: Leaders Near A Buy Point - Broadcom Inc. at $414.14, 0.10%, volume change 36%. IBD Sector Leaders - Backstory: The company is a supplier for Apple and other companies but has positioned well in dynamic industries such AI, electrification, telecom infrastructure and automation. In total, 47% of shares are held by funds. Mutual funds owning a pie… AVGO appeared in Leaders list as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating D, report May 25, 2026. Schwab Research Morningstar: rating 4 stars, report April 20, 2026.
• MarketSurge: actionable setup, buy point $412.85, buy zone top $433.49.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 4 stars, report April 20, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating D, report May 25, 2026.
• Schwab Research Morningstar: rating 4 stars, report April 20, 2026.
• Schwab Research CFRA: rating 4 stars, report May 16, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,323.18, or 8.0% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $375.95.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.0% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 87, RS 80, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating A, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 22, 2026.
• MarketSurge: extended setup, buy point $288.62, buy zone top $303.05.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 22, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating A, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 22, 2026.
• Schwab Research CFRA: rating 4 stars, report May 16, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• Fund support is strong.

Schwab changed

• Schwab: Mike already owns 50.0453 shares, worth $15,454.99, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $274.02.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AAPL is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 88, RS 89, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating B, report May 25, 2026. Schwab Research Morningstar: rating 3 stars, report April 15, 2026.
• MarketSurge: extended setup, buy point $1,522.43, buy zone top $1,598.55.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 3 stars, report April 15, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating B, report May 25, 2026.
• Schwab Research Morningstar: rating 3 stars, report April 15, 2026.
• Schwab Research CFRA: rating 5 stars, report May 16, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.

Schwab changed

• Schwab: Mike already owns 10 shares, worth $16,329.00, or 8.6% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $1,453.76.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• ASML is already 8.6% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: IBD Leaderboard.
• Leaderboard/source context: IBD Leaderboard member evidence: Leaders Near A Buy Point - TechnipFMC plc at $70.99, 0.59%, volume change 61%. FTI appeared in Leaders list as a market-leader or stock-list item. FTI appeared in Leaders watchlist as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating B, report May 25, 2026. Schwab Research CFRA: rating buy, report May 16, 2026.
• MarketSurge check: extended setup, buy point $41.27, buy zone top $43.33.
• Market direction is a confirmed uptrend.
• Composite 96 meets Mike's threshold.

Schwab changed

• Schwab: no current position found.
• Charlie should not draft a buy until the failed rule checks clear and Mike has a stop plan.

Charlie reasoned

• Leaderboard makes this worth watching, but it does not clear Mike's full buy bar today.
• The main blocker is: Industry group rank 145 is outside Mike's preferred top 10.
• This is discovery, not an order recommendation.

Source evidence

• IBD list evidence: IBD Leaderboard.
• Leaderboard/source context: IBD Leaderboard member evidence: Leaders Near A Buy Point - GE Vernova, Inc. at $1038.74, 0.49%, volume change 41%. GEV appeared in Leaders list as a market-leader or stock-list item. GEV appeared in Leaders watchlist as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating B, report May 25, 2026. Schwab Research CFRA: rating buy, report May 16, 2026.
• MarketSurge check: extended setup, buy point $731.51, buy zone top $768.09.
• Market direction is a confirmed uptrend.
• Composite 93 meets Mike's threshold.

Schwab changed

• Schwab: no current position found.
• Charlie should not draft a buy until the failed rule checks clear and Mike has a stop plan.

Charlie reasoned

• Leaderboard makes this worth watching, but it does not clear Mike's full buy bar today.
• The main blocker is: EPS 85 is below Mike's 90+ threshold.
• This is discovery, not an order recommendation.

Source evidence

• IBD list evidence: IBD Leaderboard, MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 84, Group Rank 145.
• IBD article context: IBD Leaderboard member evidence: Leaders Near A Buy Point - Broadcom Inc. at $414.14, 0.10%, volume change 36%. IBD Sector Leaders - Backstory: The company is a supplier for Apple and other companies but has positioned well in dynamic industries such AI, electrification, telecom infrastructure and automation. In total, 47% of shares are held by funds. Mutual funds owning a pie… AVGO appeared in Leaders list as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating D, report May 25, 2026. Schwab Research Morningstar: rating 4 stars, report April 20, 2026.
• MarketSurge: actionable setup, buy point $412.85, buy zone top $433.49.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 4 stars, report April 20, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating D, report May 25, 2026.
• Schwab Research Morningstar: rating 4 stars, report April 20, 2026.
• Schwab Research CFRA: rating 4 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,323.18, or 8.0% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $375.95.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.0% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 87, RS 80, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating A, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 22, 2026.
• MarketSurge: extended setup, buy point $288.62, buy zone top $303.05.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 22, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating A, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 22, 2026.
• Schwab Research CFRA: rating 4 stars, report May 16, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• Fund support is strong.

Schwab changed

• Schwab: Mike already owns 50.0453 shares, worth $15,454.99, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $274.02.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AAPL is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 88, RS 89, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating B, report May 25, 2026. Schwab Research Morningstar: rating 3 stars, report April 15, 2026.
• MarketSurge: extended setup, buy point $1,522.43, buy zone top $1,598.55.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 3 stars, report April 15, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating B, report May 25, 2026.
• Schwab Research Morningstar: rating 3 stars, report April 15, 2026.
• Schwab Research CFRA: rating 5 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.

Schwab changed

• Schwab: Mike already owns 10 shares, worth $16,329.00, or 8.6% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $1,453.76.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• ASML is already 8.6% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: IBD Leaderboard.
• Leaderboard/source context: IBD Leaderboard member evidence: Leaders Near A Buy Point - TechnipFMC plc at $70.99, 0.59%, volume change 61%. FTI appeared in Leaders list as a market-leader or stock-list item. FTI appeared in Leaders watchlist as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating B, report May 25, 2026. Schwab Research CFRA: rating buy, report May 16, 2026.
• MarketSurge check: extended setup, buy point $41.27, buy zone top $43.33.
• Market direction is a confirmed uptrend.
• Composite 96 meets Mike's threshold.

Schwab changed

• Schwab: no current position found.
• Charlie should not draft a buy until the failed rule checks clear and Mike has a stop plan.

Charlie reasoned

• Leaderboard makes this worth watching, but it does not clear Mike's full buy bar today.
• The main blocker is: Industry group rank 145 is outside Mike's preferred top 10.
• This is discovery, not an order recommendation.

Source evidence

• IBD list evidence: IBD Leaderboard.
• Leaderboard/source context: IBD Leaderboard member evidence: Leaders Near A Buy Point - GE Vernova, Inc. at $1038.74, 0.49%, volume change 41%. GEV appeared in Leaders list as a market-leader or stock-list item. GEV appeared in Leaders watchlist as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 3 stars, report April 22, 2026.
• MarketSurge check: extended setup, buy point $731.51, buy zone top $768.09.
• Market direction is a confirmed uptrend.
• Composite 93 meets Mike's threshold.

Schwab changed

• Schwab: no current position found.
• Charlie should not draft a buy until the failed rule checks clear and Mike has a stop plan.

Charlie reasoned

• Leaderboard makes this worth watching, but it does not clear Mike's full buy bar today.
• The main blocker is: EPS 85 is below Mike's 90+ threshold.
• This is discovery, not an order recommendation.

Source evidence

• IBD list evidence: IBD Leaderboard, MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 84, Group Rank 145.
• IBD article context: IBD Leaderboard member evidence: Leaders Near A Buy Point - Broadcom Inc. at $414.14, 0.10%, volume change 36%. IBD Sector Leaders - Backstory: The company is a supplier for Apple and other companies but has positioned well in dynamic industries such AI, electrification, telecom infrastructure and automation. In total, 47% of shares are held by funds. Mutual funds owning a pie… AVGO appeared in Leaders list as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating D, report May 25, 2026. Schwab Research Morningstar: rating 4 stars, report April 20, 2026.
• MarketSurge: actionable setup, buy point $412.85, buy zone top $433.49.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 4 stars, report April 20, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating D, report May 25, 2026.
• Schwab Research Morningstar: rating 4 stars, report April 20, 2026.
• Schwab Research CFRA: rating 4 stars, report May 16, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,323.18, or 8.0% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $375.95.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.0% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 87, RS 80, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating A, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 22, 2026.
• MarketSurge: extended setup, buy point $288.62, buy zone top $303.05.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 22, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating A, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 22, 2026.
• Schwab Research CFRA: rating 4 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• Fund support is strong.

Schwab changed

• Schwab: Mike already owns 50.0453 shares, worth $15,454.99, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $274.02.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AAPL is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 88, RS 89, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating B, report May 25, 2026. Schwab Research Morningstar: rating 3 stars, report April 15, 2026.
• MarketSurge: extended setup, buy point $1,522.43, buy zone top $1,598.55.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 3 stars, report April 15, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating B, report May 25, 2026.
• Schwab Research Morningstar: rating 3 stars, report April 15, 2026.
• Schwab Research CFRA: rating 5 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.

Schwab changed

• Schwab: Mike already owns 10 shares, worth $16,329.00, or 8.6% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $1,453.76.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• ASML is already 8.6% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: IBD Leaderboard.
• Leaderboard/source context: IBD Leaderboard member evidence: Leaders Near A Buy Point - TechnipFMC plc at $70.99, 0.59%, volume change 61%. FTI appeared in Leaders list as a market-leader or stock-list item. FTI appeared in Leaders watchlist as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating B, report May 25, 2026. Schwab Research CFRA: rating buy, report May 16, 2026.
• MarketSurge check: extended setup, buy point $41.27, buy zone top $43.33.
• Market direction is a confirmed uptrend.
• Composite 96 meets Mike's threshold.

Schwab changed

• Schwab: no current position found.
• Charlie should not draft a buy until the failed rule checks clear and Mike has a stop plan.

Charlie reasoned

• Leaderboard makes this worth watching, but it does not clear Mike's full buy bar today.
• The main blocker is: Industry group rank 145 is outside Mike's preferred top 10.
• This is discovery, not an order recommendation.

Source evidence

• IBD list evidence: IBD Leaderboard.
• Leaderboard/source context: IBD Leaderboard member evidence: Leaders Near A Buy Point - GE Vernova, Inc. at $1038.74, 0.49%, volume change 41%. GEV appeared in Leaders list as a market-leader or stock-list item. GEV appeared in Leaders watchlist as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 3 stars, report April 22, 2026.
• MarketSurge check: extended setup, buy point $731.51, buy zone top $768.09.
• Market direction is a confirmed uptrend.
• Composite 93 meets Mike's threshold.

Schwab changed

• Schwab: no current position found.
• Charlie should not draft a buy until the failed rule checks clear and Mike has a stop plan.

Charlie reasoned

• Leaderboard makes this worth watching, but it does not clear Mike's full buy bar today.
• The main blocker is: EPS 85 is below Mike's 90+ threshold.
• This is discovery, not an order recommendation.

Source evidence

• IBD list evidence: IBD Leaderboard, MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 84, Group Rank 145.
• IBD article context: IBD Leaderboard member evidence: Leaders Near A Buy Point - Broadcom Inc. at $414.14, 0.10%, volume change 36%. IBD Sector Leaders - Backstory: The company is a supplier for Apple and other companies but has positioned well in dynamic industries such AI, electrification, telecom infrastructure and automation. In total, 47% of shares are held by funds. Mutual funds owning a pie… AVGO appeared in Leaders list as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating D, report May 25, 2026. Schwab Research Morningstar: rating 4 stars, report April 20, 2026.
• MarketSurge: actionable setup, buy point $412.85, buy zone top $433.49.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 4 stars, report April 20, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating D, report May 25, 2026.
• Schwab Research Morningstar: rating 4 stars, report April 20, 2026.
• Schwab Research CFRA: rating 4 stars, report May 16, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,323.18, or 8.0% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $375.95.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.0% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 87, RS 80, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating A, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 22, 2026.
• MarketSurge: extended setup, buy point $288.62, buy zone top $303.05.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 22, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating A, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 22, 2026.
• Schwab Research CFRA: rating 4 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• Fund support is strong.

Schwab changed

• Schwab: Mike already owns 50.0453 shares, worth $15,454.99, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $274.02.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AAPL is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 88, RS 89, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating B, report May 25, 2026. Schwab Research Morningstar: rating 3 stars, report April 15, 2026.
• MarketSurge: extended setup, buy point $1,522.43, buy zone top $1,598.55.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 3 stars, report April 15, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating B, report May 25, 2026.
• Schwab Research Morningstar: rating 3 stars, report April 15, 2026.
• Schwab Research CFRA: rating 5 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.

Schwab changed

• Schwab: Mike already owns 10 shares, worth $16,329.00, or 8.6% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $1,453.76.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• ASML is already 8.6% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: IBD Leaderboard.
• Leaderboard/source context: IBD Leaderboard member evidence: Leaders Near A Buy Point - TechnipFMC plc at $70.99, 0.59%, volume change 61%. FTI appeared in Leaders list as a market-leader or stock-list item. FTI appeared in Leaders watchlist as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating B, report May 25, 2026. Schwab Research CFRA: rating buy, report May 16, 2026.
• MarketSurge check: extended setup, buy point $41.27, buy zone top $43.33.
• Market direction is a confirmed uptrend.
• Composite 96 meets Mike's threshold.

Schwab changed

• Schwab: no current position found.
• Charlie should not draft a buy until the failed rule checks clear and Mike has a stop plan.

Charlie reasoned

• Leaderboard makes this worth watching, but it does not clear Mike's full buy bar today.
• The main blocker is: Industry group rank 145 is outside Mike's preferred top 10.
• This is discovery, not an order recommendation.

Source evidence

• IBD list evidence: IBD Leaderboard.
• Leaderboard/source context: IBD Leaderboard member evidence: Leaders Near A Buy Point - GE Vernova, Inc. at $1038.74, 0.49%, volume change 41%. GEV appeared in Leaders list as a market-leader or stock-list item. GEV appeared in Leaders watchlist as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 3 stars, report April 22, 2026.
• MarketSurge check: extended setup, buy point $731.51, buy zone top $768.09.
• Market direction is a confirmed uptrend.
• Composite 93 meets Mike's threshold.

Schwab changed

• Schwab: no current position found.
• Charlie should not draft a buy until the failed rule checks clear and Mike has a stop plan.

Charlie reasoned

• Leaderboard makes this worth watching, but it does not clear Mike's full buy bar today.
• The main blocker is: EPS 85 is below Mike's 90+ threshold.
• This is discovery, not an order recommendation.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +0.9% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 20 share(s), worth $13,711.00, or 7.2% of the portfolio.
• Estimated current price from Schwab market value is $685.55.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for VOO.
• VOO is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +313.1% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 149 share(s), worth $11,692.03, or 6.1% of the portfolio.
• Estimated current price from Schwab market value is $78.47.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMB.
• WMB is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -1.5% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 30 share(s), worth $11,489.10, or 6.0% of the portfolio.
• Estimated current price from Schwab market value is $382.97.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for GOOGL.
• GOOGL is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -1.9% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 50 share(s), worth $10,766.50, or 5.6% of the portfolio.
• Estimated current price from Schwab market value is $215.33.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for NVDA.
• NVDA is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +0.5% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 40 share(s), worth $10,652.80, or 5.6% of the portfolio.
• Estimated current price from Schwab market value is $266.32.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for AMZN.
• AMZN is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +15.7% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 59 share(s), worth $7,095.93, or 3.7% of the portfolio.
• Estimated current price from Schwab market value is $120.27.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMT.
• WMT is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab, IBD article API, MarketSurge, and market quotes are fresh enough for required checks.
• 1 deeper required source surface(s) still need coverage before Charlie should make buy calls.
• MarketSurge per-ticker deep reads

Schwab changed

• Schwab account context is available, so Charlie can guard against duplicate or oversized buys.
• Before adding risk, review current positions and missing stop prices.

Charlie reasoned

• This is a no-new-buy state, not a no-advice state: Charlie can still recommend stop-loss cleanup from Schwab data.
• Charlie can still help Mike review existing positions, stops, source headlines, and watch candidates while he gathers the missing evidence.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +0.9% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 20 share(s), worth $13,711.00, or 7.2% of the portfolio.
• Estimated current price from Schwab market value is $685.55.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for VOO.
• VOO is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +313.1% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 149 share(s), worth $11,692.03, or 6.1% of the portfolio.
• Estimated current price from Schwab market value is $78.47.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMB.
• WMB is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -1.5% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 30 share(s), worth $11,489.10, or 6.0% of the portfolio.
• Estimated current price from Schwab market value is $382.97.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for GOOGL.
• GOOGL is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -1.9% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 50 share(s), worth $10,766.50, or 5.6% of the portfolio.
• Estimated current price from Schwab market value is $215.33.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for NVDA.
• NVDA is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +0.5% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 40 share(s), worth $10,652.80, or 5.6% of the portfolio.
• Estimated current price from Schwab market value is $266.32.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for AMZN.
• AMZN is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +15.7% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 59 share(s), worth $7,095.93, or 3.7% of the portfolio.
• Estimated current price from Schwab market value is $120.27.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMT.
• WMT is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab, IBD article API, MarketSurge, and market quotes are fresh enough for required checks.
• 1 deeper required source surface(s) still need coverage before Charlie should make buy calls.
• MarketSurge per-ticker deep reads

Schwab changed

• Schwab account context is available, so Charlie can guard against duplicate or oversized buys.
• Before adding risk, review current positions and missing stop prices.

Charlie reasoned

• This is a no-new-buy state, not a no-advice state: Charlie can still recommend stop-loss cleanup from Schwab data.
• Charlie can still help Mike review existing positions, stops, source headlines, and watch candidates while he gathers the missing evidence.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +0.9% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 20 share(s), worth $13,711.00, or 7.2% of the portfolio.
• Estimated current price from Schwab market value is $685.55.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for VOO.
• VOO is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +313.1% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 149 share(s), worth $11,692.03, or 6.1% of the portfolio.
• Estimated current price from Schwab market value is $78.47.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMB.
• WMB is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -1.5% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 30 share(s), worth $11,489.10, or 6.0% of the portfolio.
• Estimated current price from Schwab market value is $382.97.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for GOOGL.
• GOOGL is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -1.9% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 50 share(s), worth $10,766.50, or 5.6% of the portfolio.
• Estimated current price from Schwab market value is $215.33.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for NVDA.
• NVDA is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +0.5% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 40 share(s), worth $10,652.80, or 5.6% of the portfolio.
• Estimated current price from Schwab market value is $266.32.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for AMZN.
• AMZN is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +15.7% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 59 share(s), worth $7,095.93, or 3.7% of the portfolio.
• Estimated current price from Schwab market value is $120.27.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMT.
• WMT is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• marketSurge is 89 minutes old; maximum allowed is 75.

Schwab changed

Charlie reasoned

• Charlie can still make Schwab-backed risk and stop-loss recommendations for existing holdings, but he should not make new buy calls while a required IBD/MarketSurge source is blocked.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +0.9% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 20 share(s), worth $13,711.00, or 7.2% of the portfolio.
• Estimated current price from Schwab market value is $685.55.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for VOO.
• VOO is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +313.1% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 149 share(s), worth $11,692.03, or 6.1% of the portfolio.
• Estimated current price from Schwab market value is $78.47.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMB.
• WMB is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -1.5% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 30 share(s), worth $11,489.10, or 6.0% of the portfolio.
• Estimated current price from Schwab market value is $382.97.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for GOOGL.
• GOOGL is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is -1.9% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 50 share(s), worth $10,766.50, or 5.6% of the portfolio.
• Estimated current price from Schwab market value is $215.33.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for NVDA.
• NVDA is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +0.5% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 40 share(s), worth $10,652.80, or 5.6% of the portfolio.
• Estimated current price from Schwab market value is $266.32.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for AMZN.
• AMZN is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• Schwab: this position is in Mike's account and Helm does not see an open Schwab stop order or manual stop price for it.
• Schwab: current value is +15.7% versus recorded cost basis.
• IBD/MarketSurge depth is not required to set a protective sell line for an existing holding.

Schwab changed

• Schwab: Mike owns 59 share(s), worth $7,095.93, or 3.7% of the portfolio.
• Estimated current price from Schwab market value is $120.27.

Charlie reasoned

• Before adding any new risk, Mike should know the sell line for WMT.
• WMT is already owned, so the immediate recommendation is risk control, not another buy.

Source evidence

• marketSurge is 88 minutes old; maximum allowed is 75.

Schwab changed

Charlie reasoned

• Charlie can still make Schwab-backed risk and stop-loss recommendations for existing holdings, but he should not make new buy calls while a required IBD/MarketSurge source is blocked.

Source evidence

• IBD list evidence: IBD Leaderboard, MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 84, Group Rank 145.
• IBD article context: IBD Leaderboard member evidence: Leaders Near A Buy Point - Broadcom Inc. at $414.14, 0.10%, volume change 36%. IBD Sector Leaders - Backstory: The company is a supplier for Apple and other companies but has positioned well in dynamic industries such AI, electrification, telecom infrastructure and automation. In total, 47% of shares are held by funds. Mutual funds owning a pie… AVGO appeared in Leaders list as a market-leader or stock-list item. IBD article 2026-05-23: These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Solar Stock Tops Buy Point. As the stock market continues to trade near all-time highs, it's important to watch the stocks that are holding up and are most loved by equity analysts. They may end up being market leaders. Five Below ( FIVE ), Fabrinet ( FN ) and Alamos Gold ( AGI ) are three of the seven best stocks where investors can find magnificent profit growth prospects.... Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: actionable setup, buy point $412.85, buy zone top $433.49.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,323.18, or 8.0% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $375.95.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.0% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 87, RS 80, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: extended setup, buy point $288.62, buy zone top $303.05.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• Fund support is strong.

Schwab changed

• Schwab: Mike already owns 50.0453 shares, worth $15,454.99, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $274.02.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AAPL is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 88, RS 89, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: extended setup, buy point $1,522.43, buy zone top $1,598.55.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.

Schwab changed

• Schwab: Mike already owns 10 shares, worth $16,329.00, or 8.6% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $1,453.76.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• ASML is already 8.6% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: IBD Leaderboard.
• Leaderboard/source context: IBD Leaderboard member evidence: Leaders Near A Buy Point - TechnipFMC plc at $70.99, 0.59%, volume change 61%. FTI appeared in Leaders list as a market-leader or stock-list item. FTI appeared in Leaders watchlist as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge check: extended setup, buy point $41.27, buy zone top $43.33.
• Market direction is a confirmed uptrend.
• Composite 96 meets Mike's threshold.

Schwab changed

• Schwab: no current position found.
• Charlie should not draft a buy until the failed rule checks clear and Mike has a stop plan.

Charlie reasoned

• Leaderboard makes this worth watching, but it does not clear Mike's full buy bar today.
• The main blocker is: Industry group rank 145 is outside Mike's preferred top 10.
• This is discovery, not an order recommendation.

Source evidence

• IBD list evidence: IBD Leaderboard.
• Leaderboard/source context: IBD Leaderboard member evidence: Leaders Near A Buy Point - GE Vernova, Inc. at $1038.74, 0.49%, volume change 41%. GEV appeared in Leaders list as a market-leader or stock-list item. GEV appeared in Leaders watchlist as a market-leader or stock-list item. IBD article 2026-05-23: Amazon, GE Vernova Lead 5 Stocks Near Buy Points In Strong Market. Amazon.com ( AMZN ) leads this weekend's watch list of five top stocks near buy points as the bull market marches on, though a bit more slowly. AMZN is joined by a pair of AI stocks and S&P 500 members, Cadence Design Systems ( CDNS ), whose software tools are used to design advanced semiconductors, and GE Vernova ( GEV ), whose gas turbines power data centers.... Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge check: extended setup, buy point $731.51, buy zone top $768.09.
• Market direction is a confirmed uptrend.
• Composite 93 meets Mike's threshold.

Schwab changed

• Schwab: no current position found.
• Charlie should not draft a buy until the failed rule checks clear and Mike has a stop plan.

Charlie reasoned

• Leaderboard makes this worth watching, but it does not clear Mike's full buy bar today.
• The main blocker is: EPS 85 is below Mike's 90+ threshold.
• This is discovery, not an order recommendation.

Source evidence

• IBD list evidence: IBD Leaderboard.
• Leaderboard/source context: IBD Leaderboard member evidence: Leaders Near A Buy Point - Valero Energy Corp. at $246.96, 2.43%, volume change 31%. VLO appeared in Stock Spotlight as a market-leader or stock-list item. VLO appeared in Leaders list as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls.
• MarketSurge check: forming setup, buy point $254.60, buy zone top $267.33.
• Market direction is a confirmed uptrend.
• Composite 91 meets Mike's threshold.

Schwab changed

• Schwab: no current position found.
• Charlie should not draft a buy until the failed rule checks clear and Mike has a stop plan.

Charlie reasoned

• Leaderboard makes this worth watching, but it does not clear Mike's full buy bar today.
• The main blocker is: EPS 86 is below Mike's 90+ threshold.
• This is discovery, not an order recommendation.

Source evidence

• IBD list evidence: IBD Leaderboard.
• Leaderboard/source context: IBD Leaderboard member evidence: Leaders Near A Buy Point - Revolution Medicines, Inc. at $151.56, 1.41%, volume change 37%. RVMD appeared in Leaders list as a market-leader or stock-list item. RVMD appeared in Leaders watchlist as a market-leader or stock-list item. MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls.
• MarketSurge check: extended setup, buy point $124.23, buy zone top $130.44.
• Market direction is a confirmed uptrend.
• RS 97 is strong.

Schwab changed

• Schwab: no current position found.
• Charlie should not draft a buy until the failed rule checks clear and Mike has a stop plan.

Charlie reasoned

• Leaderboard makes this worth watching, but it does not clear Mike's full buy bar today.
• The main blocker is: Composite 52 is below Mike's 90+ threshold.
• This is discovery, not an order recommendation.

Source evidence

• IBD list evidence: IBD Leaderboard, MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 84, Group Rank 145.
• IBD article context: IBD Leaderboard member evidence: Leaders Near A Buy Point - Broadcom Inc. at $414.14, 0.10%, volume change 36%. IBD Sector Leaders - Backstory: The company is a supplier for Apple and other companies but has positioned well in dynamic industries such AI, electrification, telecom infrastructure and automation. In total, 47% of shares are held by funds. Mutual funds owning a pie… AVGO appeared in Leaders list as a market-leader or stock-list item. IBD article 2026-05-23: These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Solar Stock Tops Buy Point. As the stock market continues to trade near all-time highs, it's important to watch the stocks that are holding up and are most loved by equity analysts. They may end up being market leaders. Five Below ( FIVE ), Fabrinet ( FN ) and Alamos Gold ( AGI ) are three of the seven best stocks where investors can find magnificent profit growth prospects.... Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: actionable setup, buy point $412.85, buy zone top $433.49.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,323.18, or 8.0% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $375.95.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.0% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 87, RS 80, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: extended setup, buy point $288.62, buy zone top $303.05.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• Fund support is strong.

Schwab changed

• Schwab: Mike already owns 50.0453 shares, worth $15,454.99, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $274.02.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AAPL is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 88, RS 89, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: extended setup, buy point $1,522.43, buy zone top $1,598.55.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.

Schwab changed

• Schwab: Mike already owns 10 shares, worth $16,329.00, or 8.6% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $1,453.76.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• ASML is already 8.6% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: IBD Leaderboard, MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 84, Group Rank 145.
• IBD article context: IBD Leaderboard member evidence: Leaders Near A Buy Point - Broadcom Inc. at $414.14, 0.10%, volume change 36%. IBD Sector Leaders - Backstory: The company is a supplier for Apple and other companies but has positioned well in dynamic industries such AI, electrification, telecom infrastructure and automation. In total, 47% of shares are held by funds. Mutual funds owning a pie… AVGO appeared in Leaders list as a market-leader or stock-list item. IBD article 2026-05-23: These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Solar Stock Tops Buy Point. As the stock market continues to trade near all-time highs, it's important to watch the stocks that are holding up and are most loved by equity analysts. They may end up being market leaders. Five Below ( FIVE ), Fabrinet ( FN ) and Alamos Gold ( AGI ) are three of the seven best stocks where investors can find magnificent profit growth prospects.... Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: actionable setup, buy point $412.85, buy zone top $433.49.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,323.18, or 8.0% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $375.95.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.0% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 87, RS 80, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: extended setup, buy point $288.62, buy zone top $303.05.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• Fund support is strong.

Schwab changed

• Schwab: Mike already owns 50.0453 shares, worth $15,454.99, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $274.02.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AAPL is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 88, RS 89, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: extended setup, buy point $1,522.43, buy zone top $1,598.55.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.

Schwab changed

• Schwab: Mike already owns 10 shares, worth $16,329.00, or 8.6% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $1,453.76.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• ASML is already 8.6% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: IBD Leaderboard, MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 84, Group Rank 145.
• IBD article context: IBD Leaderboard member evidence: Leaders Near A Buy Point - Broadcom Inc. at $414.14, 0.10%, volume change 36%. IBD Sector Leaders - Backstory: The company is a supplier for Apple and other companies but has positioned well in dynamic industries such AI, electrification, telecom infrastructure and automation. In total, 47% of shares are held by funds. Mutual funds owning a pie… AVGO appeared in Leaders list as a market-leader or stock-list item. IBD article 2026-05-23: These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Solar Stock Tops Buy Point. As the stock market continues to trade near all-time highs, it's important to watch the stocks that are holding up and are most loved by equity analysts. They may end up being market leaders. Five Below ( FIVE ), Fabrinet ( FN ) and Alamos Gold ( AGI ) are three of the seven best stocks where investors can find magnificent profit growth prospects.... Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: actionable setup, buy point $412.85, buy zone top $433.49.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,323.18, or 8.0% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $375.95.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.0% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 87, RS 80, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: extended setup, buy point $288.62, buy zone top $303.05.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• Fund support is strong.

Schwab changed

• Schwab: Mike already owns 50.0453 shares, worth $15,454.99, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $274.02.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AAPL is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 88, RS 89, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: extended setup, buy point $1,522.43, buy zone top $1,598.55.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.

Schwab changed

• Schwab: Mike already owns 10 shares, worth $16,329.00, or 8.6% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $1,453.76.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• ASML is already 8.6% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: IBD Leaderboard, MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 84, Group Rank 145.
• IBD article context: IBD Leaderboard member evidence: Leaders Near A Buy Point - Broadcom Inc. at $414.14, 0.10%, volume change 36%. IBD Sector Leaders - Backstory: The company is a supplier for Apple and other companies but has positioned well in dynamic industries such AI, electrification, telecom infrastructure and automation. In total, 47% of shares are held by funds. Mutual funds owning a pie… AVGO appeared in Leaders list as a market-leader or stock-list item. IBD article 2026-05-23: These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Solar Stock Tops Buy Point. As the stock market continues to trade near all-time highs, it's important to watch the stocks that are holding up and are most loved by equity analysts. They may end up being market leaders. Five Below ( FIVE ), Fabrinet ( FN ) and Alamos Gold ( AGI ) are three of the seven best stocks where investors can find magnificent profit growth prospects.... Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: actionable setup, buy point $412.85, buy zone top $433.49.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,323.18, or 8.0% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $375.95.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.0% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 87, RS 80, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: extended setup, buy point $288.62, buy zone top $303.05.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• Fund support is strong.

Schwab changed

• Schwab: Mike already owns 50.0453 shares, worth $15,454.99, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $274.02.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AAPL is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD list evidence: MarketSurge chart read, Schwab holding.
• IBD-style ratings via MarketSurge: Composite 99, EPS 88, RS 89, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026. Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• MarketSurge: extended setup, buy point $1,522.43, buy zone top $1,598.55.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar shows 2 stars, report May 4, 2026. Morningstar quality/moat field is present but needs a cleaner read.
• Schwab Research Schwab Equity Ratings: rating C, report May 25, 2026.
• Schwab Research Morningstar: rating 2 stars, report May 4, 2026.
• Schwab Research CFRA: rating 3 stars, report May 23, 2026.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.

Schwab changed

• Schwab: Mike already owns 10 shares, worth $16,329.00, or 8.6% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $1,453.76.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• ASML is already 8.6% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 85, Group Rank 21.
• IBD article context: IBD article 2026-05-20: Nvidia Stock Rises Ahead Of Fiscal Q1 Report (Live Coverage). It's a foregone conclusion on Wall Street that Nvidia ( NVDA ) will deliver a strong fiscal first-quarter report after the market closes Wednesday. The big question is whether it will be enough to lift Nvidia stock. After all, Nvidia stock has fallen the day after five of the last seven earnings reports. Most recently, it dropped 5.5% the day after its knockout fiscal Q4 report on Feb. 25.... Schwab Research context: Schwab financial page sections: earnings missing, peers/ratios missing, statements missing. Schwab News: News Disclosures (Schwab Network is brought to you by Charles Schwab Media Productions Company (“CSMPC”).  CSMPC and Charles Schwab & Co., Inc. are separate but affiliated subsidiaries of The Charles Schwab Corporation. CSMPC is not a financial advisor, registered investment advisor, broker-dealer, or futures commission merchant.).
• MarketSurge: actionable setup, buy point $413.44, buy zone top $434.11.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar was not captured for this ticker yet. Quality/moat context is pending.
• Schwab financial page sections: earnings missing, peers/ratios missing, statements missing.
• Schwab News: News Disclosures (Schwab Network is brought to you by Charles Schwab Media Productions Company (“CSMPC”).  CSMPC and Charles Schwab & Co., Inc. are separate but affiliated subsidiaries of The Charles Schwab Corporation. CSMPC is not a financial advisor, registered investment advisor, broker-dealer, or futures commission merchant.).
• Schwab News: Schwab Market Update is brought to you The Schwab Center for Financial Research which is a division of Charles Schwab & Co., Inc. (All other news sources used on Schwab come from independent third parties. Schwab or any of its subsidiaries are not affiliated with any of the other news content providers. Schwab is not responsible for the content, and does not write or control which particular articles appear.).
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,447.48, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $375.95.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD-style ratings via MarketSurge: Composite 96, EPS 88, RS 84, Group Rank 26.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls. Schwab Research context: Schwab financial page sections: earnings missing, peers/ratios missing, statements missing. Schwab News: News Disclosures (Schwab Network is brought to you by Charles Schwab Media Productions Company (“CSMPC”).  CSMPC and Charles Schwab & Co., Inc. are separate but affiliated subsidiaries of The Charles Schwab Corporation. CSMPC is not a financial advisor, registered investment advisor, broker-dealer, or futures commission merchant.).
• MarketSurge: actionable setup, buy point $1,540.50, buy zone top $1,617.53.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Schwab-hosted Morningstar was not captured for this ticker yet. Quality/moat context is pending.
• Schwab financial page sections: earnings missing, peers/ratios missing, statements missing.
• Schwab News: News Disclosures (Schwab Network is brought to you by Charles Schwab Media Productions Company (“CSMPC”).  CSMPC and Charles Schwab & Co., Inc. are separate but affiliated subsidiaries of The Charles Schwab Corporation. CSMPC is not a financial advisor, registered investment advisor, broker-dealer, or futures commission merchant.).
• Schwab News: Schwab Market Update is brought to you The Schwab Center for Financial Research which is a division of Charles Schwab & Co., Inc. (All other news sources used on Schwab come from independent third parties. Schwab or any of its subsidiaries are not affiliated with any of the other news content providers. Schwab is not responsible for the content, and does not write or control which particular articles appear.).
• Market direction is a confirmed uptrend.
• Composite 96 meets Mike's threshold.
• MarketSurge chart setup is actionable.

Schwab changed

• Schwab: Mike already owns 10 shares, worth $15,399.85, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $1,410.71.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• ASML is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 85, Group Rank 21.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls.
• MarketSurge: forming setup, buy point $416.14, buy zone top $436.95.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Morningstar is not connected yet; valuation discipline still needs to be added. Quality/moat context is pending.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,274.34, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $375.95.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 85, Group Rank 21.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls.
• MarketSurge: forming setup, buy point $416.14, buy zone top $436.95.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Morningstar is not connected yet; valuation discipline still needs to be added. Quality/moat context is pending.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,265.09, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $375.95.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 85, Group Rank 21.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls.
• MarketSurge: forming setup, buy point $416.14, buy zone top $436.95.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Morningstar is not connected yet; valuation discipline still needs to be added. Quality/moat context is pending.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,265.09, or 8.1% of the portfolio.
• Schwab.com confirms an open trailing/stop order near $375.95.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.1% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 86, Group Rank 16.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls.
• MarketSurge: actionable setup, buy point $416.24, buy zone top $437.05.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Morningstar is not connected yet; valuation discipline still needs to be added. Quality/moat context is pending.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,565.16, or 8.2% of the portfolio.
• No current stop price is on file.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.2% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD-style ratings via MarketSurge: Composite 99, EPS 99, RS 92, Group Rank 33.
• IBD article context: IBD article 2026-05-18: Stock Market Today: Dow Rises, Nasdaq Cuts Loss As Trump Delays Iran Attack; Nvidia Falls (Live Coverage). The Dow Jones Industrial Average and other major indexes closed mixed Monday, but improved from the day's lows after President Donald Trump said he's called off a plan for the U.S. to attack Iran. Tech stocks pulled back on the stock market today as many have become extended, including Nvidia ( NVDA ) and Micron Technology ( MU ).... IBD article 2026-05-18: Amazon, IBD's Stock Of The Day, Named 'Franchise Pick' As $3 Trillion Milestone Nears. Amazon.com Amazon.com AMZN $ 264.86 $0.72 0.27% 26% IBD Stock Analysis Stock back in range of 258.60 consolidation buy point AMZN with 278.56 high handle Move above 10-day offers entry point IBD Composite Rating 97 /99 Industry Group Ranking 56 /197 Emerging Pattern Consolidation Consolidation A sideways pattern that doesn’t fit traditional base definitions. Sometimes will have a handle. * Not real-time data....
• MarketSurge: extended setup, buy point $350.28, buy zone top $367.79.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Morningstar is not connected yet; valuation discipline still needs to be added. Quality/moat context is pending.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 99 is strong.

Schwab changed

• Schwab: Mike already owns 50 shares, worth $19,964.50, or 10.5% of the portfolio.
• No current stop price is on file.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• GOOGL is already 10.5% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD-style ratings via MarketSurge: Composite 99, EPS 98, RS 81, Group Rank 16.
• IBD article context: IBD article 2026-05-18: Stocks Wrestle With Inflation Worries But End Off Lows After Trump Move; Nvidia Earnings In Sight. Rising oil prices and bond yields held sway over major stock market indexes Monday, but the Dow Jones Industrial Average ventured back into positive territory in the final hour of trade after President Donald Trump waived off a planned attack against Iran. The Dow ended up 0.3% after darting between gains and losses.... IBD article 2026-05-18: Dow Jones Futures: Trump Iran Delay Saves Dow's Day, But Sandisk, Bloom Energy, AI Leaders Sell Off. Dow Jones futures edged higher after hours, along with S&P 500 futures and Nasdaq futures. The stock market closed mixed after trading lower for much of Monday. With about an hour left in the session, President Donald Trump said on social media that he postponed a "scheduled attack of Iran tomorrow" at the request of Persian Gulf allies, saying "serious negotiations are now taking place." ↑ X Leaders Punished Again...
• MarketSurge: extended setup, buy point $199.39, buy zone top $209.36.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Morningstar is not connected yet; valuation discipline still needs to be added. Quality/moat context is pending.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 98 is strong.

Schwab changed

• Schwab: Mike already owns 70 shares, worth $15,634.50, or 8.3% of the portfolio.
• No current stop price is on file.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• NVDA is already 8.3% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD-style ratings via MarketSurge: Composite 0, EPS 0, RS 85, Group Rank 145.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls.
• MarketSurge: extended setup, buy point $640.48, buy zone top $672.50.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Morningstar is not connected yet; valuation discipline still needs to be added. Quality/moat context is pending.
• Market direction is a confirmed uptrend.
• Fund support is strong.

Schwab changed

• Schwab: Mike already owns 75 shares, worth $50,979.00, or 26.9% of the portfolio.
• No current stop price is on file.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• VOO is already 26.9% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD-style ratings via MarketSurge: Composite 99, EPS 96, RS 86, Group Rank 16.
• IBD article context: MarketSurge supplied IBD-style rating context. Charlie should still wait for clean IBD article/list coverage before new buy calls.
• MarketSurge: actionable setup, buy point $416.24, buy zone top $437.05.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Morningstar is not connected yet; valuation discipline still needs to be added. Quality/moat context is pending.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 96 is strong.

Schwab changed

• Schwab: Mike already owns 37 shares, worth $15,565.16, or 8.2% of the portfolio.
• No current stop price is on file.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• AVGO is already 8.2% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD-style ratings via MarketSurge: Composite 99, EPS 99, RS 92, Group Rank 33.
• IBD article context: IBD article 2026-05-18: Stock Market Today: Dow Rises, Nasdaq Cuts Loss As Trump Delays Iran Attack; Nvidia Falls (Live Coverage). The Dow Jones Industrial Average and other major indexes closed mixed Monday, but improved from the day's lows after President Donald Trump said he's called off a plan for the U.S. to attack Iran. Tech stocks pulled back on the stock market today as many have become extended, including Nvidia ( NVDA ) and Micron Technology ( MU ).... IBD article 2026-05-18: Amazon, IBD's Stock Of The Day, Named 'Franchise Pick' As $3 Trillion Milestone Nears. Amazon.com Amazon.com AMZN $ 264.86 $0.72 0.27% 26% IBD Stock Analysis Stock back in range of 258.60 consolidation buy point AMZN with 278.56 high handle Move above 10-day offers entry point IBD Composite Rating 97 /99 Industry Group Ranking 56 /197 Emerging Pattern Consolidation Consolidation A sideways pattern that doesn’t fit traditional base definitions. Sometimes will have a handle. * Not real-time data....
• MarketSurge: extended setup, buy point $350.28, buy zone top $367.79.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Morningstar is not connected yet; valuation discipline still needs to be added. Quality/moat context is pending.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 99 is strong.

Schwab changed

• Schwab: Mike already owns 50 shares, worth $19,964.50, or 10.5% of the portfolio.
• No current stop price is on file.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• GOOGL is already 10.5% of the portfolio, above Mike's 8% single-position guardrail.

Source evidence

• IBD-style ratings via MarketSurge: Composite 99, EPS 98, RS 81, Group Rank 16.
• IBD article context: IBD article 2026-05-18: Stocks Wrestle With Inflation Worries But End Off Lows After Trump Move; Nvidia Earnings In Sight. Rising oil prices and bond yields held sway over major stock market indexes Monday, but the Dow Jones Industrial Average ventured back into positive territory in the final hour of trade after President Donald Trump waived off a planned attack against Iran. The Dow ended up 0.3% after darting between gains and losses.... IBD article 2026-05-18: Dow Jones Futures: Trump Iran Delay Saves Dow's Day, But Sandisk, Bloom Energy, AI Leaders Sell Off. Dow Jones futures edged higher after hours, along with S&P 500 futures and Nasdaq futures. The stock market closed mixed after trading lower for much of Monday. With about an hour left in the session, President Donald Trump said on social media that he postponed a "scheduled attack of Iran tomorrow" at the request of Persian Gulf allies, saying "serious negotiations are now taking place." ↑ X Leaders Punished Again...
• MarketSurge: extended setup, buy point $199.39, buy zone top $209.36.
• Motley Fool: Motley Fool is not connected yet; Charlie is not using long-term business-story context for this ticker.
• Morningstar: Morningstar is not connected yet; valuation discipline still needs to be added. Quality/moat context is pending.
• Market direction is a confirmed uptrend.
• Composite 99 meets Mike's threshold.
• EPS 98 is strong.

Schwab changed

• Schwab: Mike already owns 70 shares, worth $15,634.50, or 8.3% of the portfolio.
• No current stop price is on file.

Charlie reasoned

• This meets Mike's rules today, but Mike already has a full-sized position.
• NVDA is already 8.3% of the portfolio, above Mike's 8% single-position guardrail.